Optcom Twitter RSS and Email Facebook
social icons_160
Marco
AcuityPro
Sigma Pharmaceuticals,  LLC
Biosyntrx
RevolutionEHR
EyeBase
  • revolution banner
17
Aug

Atropine for the Treatment of Childhood Myopia: Safety and Efficacy of 0.5%, 0.1%, and 0.01% Doses (Atropine for the Treatment of Myopia 2)

Posted by Walt Mayo, OD
Walt Mayo, OD
Optcom Founder
User is currently offline
in Remote Submission

Source: aaojournal .org

Purpose
Our previous study, Atropine for the Treatment of Myopia 1 (ATOM1), showed that atropine 1% eyedrops were effective in controlling myopic progression but with visual side effects resulting from cycloplegia and mydriasis. The aim of this study was to compare efficacy and visual side effects of 3 lower doses of atropine: 0.5%, 0.1%, and 0.01%.


http://bit.ly/R6uDjx
0 votes
Tags: Untagged

Comments

Please login first in order for you to submit comments
Newsletter
Digest
Listserv
AcuityPro